Chris Gast

Species turnover within cystic fibrosis lung microbiota is indicative of acute pulmonary exacerbation onset

WS08.03Remodelling of cystic fibrosis respiratory microbiota in response to extended elexacaftor/tezacaftor/ivacaftor therapy

Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience

Model Systems to Study the Chronic, Polymicrobial Infections in Cystic Fibrosis: Current Approaches and Exploring Future Directions

Lung function and microbiota diversity in cystic fibrosis

A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in Lithuania

Intestinal Antibody Responses to 2 Novel Live Attenuated Type 2 Oral Poliovirus Vaccines in Healthy Adults in Belgium

The gut microbiota of siblings offers insights into microbial pathogenesis of inflammatory bowel disease

Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial

Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention

Siblings of patients with Crohn’s disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities

Three Clinically Distinct Chronic Pediatric Airway Infections Share a Common Core Microbiota

Time between Collection and Storage Significantly Influences Bacterial Sequence Composition in Sputum Samples from Cystic Fibrosis Respiratory Infections

Implications of multiple freeze-thawing on respiratory samples for culture-independent analyses

Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition

Ascitic Microbiota Composition Is Correlated with Clinical Severity in Cirrhosis with Portal Hypertension

Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience

Reducing bias in bacterial community analysis of lower respiratory infections

Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis